Study finds no significant benefit of spironolactone in HFpEF or HFmrEF
A trial testing the aldosterone blocker spironolactone in patients with heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF) did not show any significant ...
Mar 31, 2026
0
5









